SquareMind Secures €15.3M for AI Dermatology Platform
Key Takeaways
- 1SquareMind raises €15.3M for its AI dermatology imaging robot
- 2Launch of Swan™ enhances skin imaging capabilities
- 3Investment supports autonomy in healthcare tech innovation
- 4SquareMind raises €15.3M for its AI dermatology imaging robot • Launch of Swan™ enhances skin imaging capabilities • Investment supports autonomy in healthcare tech innovation
SquareMind, a French startup focused on AI and robotics for dermatology, has secured €15.3 million (approximately $18 million) to commercialize its whole-body imaging robot, Swan™. This funding will facilitate the deployment of their advanced dermatological imaging platform under increasing competitive pressure in healthcare technology.
The investment represents a strategic move towards enhancing national expertise in healthcare tech, particularly in robotics and AI-related imaging solutions. By improving its proprietary technologies, SquareMind aims to reduce dependence on foreign systems while addressing healthcare demands with innovative solutions, positioning itself prominently in the burgeoning field of automated medical imaging.
Source